🚀 VC round data is live in beta, check it out!
Nahdi Medical Valuation Multiples
Discover revenue and EBITDA valuation multiples for Nahdi Medical and similar public comparables like COSMOS Pharmaceutical, CR Pharmaceutical, DaShenLin Pharmaceutical, Jointown Pharmaceutical and more.
Nahdi Medical Overview
About Nahdi Medical
Nahdi Medical Co is engaged in the wholesale and retail trading of cosmetics, pharmaceutical products, special and healthy foods, and medical equipment. It has two operating segments Front Shop and Pharma.
Founded
1986
HQ
Employees
N/A
Website
Sectors
Financials (LTM)
EV
$4B
Nahdi Medical Financials
Nahdi Medical reported last 12-month revenue of $3B and EBITDA of $461M.
In the same LTM period, Nahdi Medical generated $1B in gross profit, $461M in EBITDA, and $222M in net income.
Revenue (LTM)
Nahdi Medical P&L
In the most recent fiscal year, Nahdi Medical reported revenue of $3B and EBITDA of $430M.
Nahdi Medical expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | $3B | XXX | $3B | XXX | XXX | XXX |
| Gross Profit | $1B | XXX | $942M | XXX | XXX | XXX |
| Gross Margin | 38% | XXX | 37% | XXX | XXX | XXX |
| EBITDA | $461M | XXX | $430M | XXX | XXX | XXX |
| EBITDA Margin | 17% | XXX | 17% | XXX | XXX | XXX |
| EBIT Margin | 9% | XXX | 9% | XXX | XXX | XXX |
| Net Profit | $222M | XXX | $219M | XXX | XXX | XXX |
| Net Margin | 8% | XXX | 9% | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
Nahdi Medical Stock Performance
Nahdi Medical has current market cap of $3B, and enterprise value of $4B.
Market Cap Evolution
Nahdi Medical's stock price is $26.56.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $4B | $3B | 0.0% | XXX | XXX | XXX | $1.68 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialNahdi Medical Valuation Multiples
Nahdi Medical trades at 1.4x EV/Revenue multiple, and 8.2x EV/EBITDA.
EV / Revenue (LTM)
Nahdi Medical Financial Valuation Multiples
As of March 16, 2026, Nahdi Medical has market cap of $3B and EV of $4B.
Equity research analysts estimate Nahdi Medical's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Nahdi Medical has a P/E ratio of 15.5x.
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $3B | XXX | $3B | XXX | XXX | XXX |
| EV (current) | $4B | XXX | $4B | XXX | XXX | XXX |
| EV/Revenue | 1.4x | XXX | 1.5x | XXX | XXX | XXX |
| EV/EBITDA | 8.2x | XXX | 8.8x | XXX | XXX | XXX |
| EV/EBIT | 15.2x | XXX | 16.3x | XXX | XXX | XXX |
| EV/Gross Profit | 3.6x | XXX | 4.0x | XXX | XXX | XXX |
| P/E | 15.5x | XXX | 15.8x | XXX | XXX | XXX |
| EV/FCF | 22.2x | XXX | 12.7x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Nahdi Medical Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
Nahdi Medical Margins & Growth Rates
Nahdi Medical's revenue in the last 12 month grew by 10%.
Nahdi Medical's rule of 40 is 26% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Nahdi Medical's rule of X is 41% (created by Bessemer, rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Nahdi Medical Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 10% | XXX | 7% | XXX | XXX | XXX |
| EBITDA Margin | 17% | XXX | 17% | XXX | XXX | XXX |
| EBITDA Growth | 7% | XXX | 6% | XXX | XXX | XXX |
| Rule of 40 | — | XXX | 26% | XXX | XXX | XXX |
| Bessemer Rule of X | — | XXX | 41% | XXX | XXX | XXX |
| S&M Expenses to Revenue | — | XXX | 4% | XXX | XXX | XXX |
| G&A Expenses to Revenue | — | XXX | 1% | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 28% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Nahdi Medical Public Comps
See public comps and valuation multiples for other Pharmacies comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| COSMOS Pharmaceutical | XXX | XXX | XXX | XXX | XXX | XXX |
| CR Pharmaceutical | XXX | XXX | XXX | XXX | XXX | XXX |
| DaShenLin Pharmaceutical | XXX | XXX | XXX | XXX | XXX | XXX |
| Jointown Pharmaceutical | XXX | XXX | XXX | XXX | XXX | XXX |
| Sundrug | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Nahdi Medical M&A Activity
Nahdi Medical acquired XXX companies to date.
Last acquisition by Nahdi Medical was on XXXXXXXX, XXXXX. Nahdi Medical acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by Nahdi Medical
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialNahdi Medical Investment Activity
Nahdi Medical invested in XXX companies to date.
Nahdi Medical made its latest investment on XXXXXXXX, XXXXX. Nahdi Medical invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by Nahdi Medical
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Nahdi Medical
| When was Nahdi Medical founded? | Nahdi Medical was founded in 1986. |
| Where is Nahdi Medical headquartered? | Nahdi Medical is headquartered in Saudi Arabia. |
| Who is the CEO of Nahdi Medical? | Nahdi Medical's CEO is Yasser Ghulam Abdulaziz Joharji. |
| Is Nahdi Medical publicly listed? | Yes, Nahdi Medical is a public company listed on Tadawul. |
| What is the stock symbol of Nahdi Medical? | Nahdi Medical trades under 4164 ticker. |
| When did Nahdi Medical go public? | Nahdi Medical went public in 2022. |
| Who are competitors of Nahdi Medical? | Nahdi Medical main competitors are COSMOS Pharmaceutical, CR Pharmaceutical, DaShenLin Pharmaceutical, Jointown Pharmaceutical. |
| What is the current market cap of Nahdi Medical? | Nahdi Medical's current market cap is $3B. |
| What is the current revenue of Nahdi Medical? | Nahdi Medical's last 12 months revenue is $3B. |
| What is the current revenue growth of Nahdi Medical? | Nahdi Medical revenue growth (NTM/LTM) is 10%. |
| What is the current EV/Revenue multiple of Nahdi Medical? | Current revenue multiple of Nahdi Medical is 1.4x. |
| Is Nahdi Medical profitable? | Yes, Nahdi Medical is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Nahdi Medical? | Nahdi Medical's last 12 months EBITDA is $461M. |
| What is Nahdi Medical's EBITDA margin? | Nahdi Medical's last 12 months EBITDA margin is 17%. |
| What is the current EV/EBITDA multiple of Nahdi Medical? | Current EBITDA multiple of Nahdi Medical is 8.2x. |
| What is the current FCF of Nahdi Medical? | Nahdi Medical's last 12 months FCF is $170M. |
| What is Nahdi Medical's FCF margin? | Nahdi Medical's last 12 months FCF margin is 6%. |
| What is the current EV/FCF multiple of Nahdi Medical? | Current FCF multiple of Nahdi Medical is 22.2x. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.